| Pharmaceutical Information |
| Drug Name |
Strontium ranelate |
| Drug ID |
BADD_D02076 |
| Description |
Strontium ranelate, a strontium (II) salt of ranelic acid, is a medication for osteoporosis. Some reports have shown that strontium ranelate can slow down the progression of osteoarthritis of the knee. This agent presents an atypical mechanism of action in which it increases deposition of new bone by osteoblasts and, simultaneously, reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in treatment of severe osteoporosis.
Furthermore, various clinical studies demonstrate the ability of strontium ranelate to improve and strengthen intrinsic bone tissue quality and microarchitecture in osteoporosis by way of a number of cellular and microstructural changes by which anti-fracture efficacy is enhanced.
Available for prescription use for a time in some parts of the world as Protelos (strontium ranelate) 2 g granules for oral suspension by Servier, it was ultimately discontinued in 2016-2017 owing to an increased adverse cardiac effects profile along with increased risk of venous thromboembolism (VTE) and various life threatening allergic reactions. |
| Indications and Usage |
In postmenopausal women, strontium ranelate can also reduce the risk of vertebral and hip fractures [L1127]. |
| Marketing Status |
Not Available |
| ATC Code |
M05BX03 |
| DrugBank ID |
DB09267
|
| KEGG ID |
D08468
|
| MeSH ID |
C081587
|
| PubChem ID |
6918182
|
| TTD Drug ID |
D0X7KZ
|
| NDC Product Code |
Not Available |
| Synonyms |
strontium ranelate | protelos | S12911-5 | S12911-0 | S12911-2 | 3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt | S 12911 | S12911 | S-12911 |
|
| Chemical Information |
| Molecular Formula |
C12H6N2O8SSr2 |
| CAS Registry Number |
135459-87-9 |
| SMILES |
C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Sr+2].[Sr+2] |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
